Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Neuroscience stories

Oct 30, 2026

Ohio State researchers link gut microbiome to inflammation in spinal cord injury

Scientists at Ohio State University conducted a genome-level analysis of gut microbial communities to explore connections between spinal cord injury, inflammation, and immune function. The early study results suggest potential new therapeutic approaches to aid healing after spinal injuries.

Oct 30, 2026·3 sources
00

UCSF launches trial of wearable ultrasound device to treat schizophrenia hallucinations

The University of California, San Francisco opened the MESSI-LEO Phase 1 trial on October 30, testing a wearable 128-element ultrasound headband that targets the caudate region of the brain to reduce auditory hallucinations in schizophrenia patients. The noninvasive treatment addresses persistent hallucinations that affect approximately 40% of patients despite antipsychotic medications.

Oct 30, 2026·2 sources
00
Oct 29, 2026

Older adults' brains adapt better to sleep deprivation, Simon Fraser University study finds

Research from Simon Fraser University reveals that older adults' brains cope more effectively with lack of sleep compared to younger individuals, according to findings published in Imaging Neuroscience using functional connectivity analysis.

Oct 29, 2026·1 source
00

University of Eastern Finland identifies vitamin transporter protein for brain drug delivery

Researchers at the University of Eastern Finland have identified the SMVT transporter protein that can improve creatine delivery to the brain and potentially enable new therapies targeting the central nervous system. The discovery addresses one of medicine's greatest challenges: delivering drugs across the blood-brain barrier.

Oct 29, 2026·4 sources
00

Premature birth alters cerebellum growth and development, study finds

A new study reveals that premature infants experience altered growth and developmental trajectories in the cerebellum compared to full-term babies. The cerebellum plays a critical role in motor function, language, and cognition.

Oct 29, 2026·3 sources
00

Researchers link linoleic acid breakdown product to psoriasis itch through GPR35 receptor

Scientists have discovered that EKODE, a metabolite of commonly consumed linoleic acid fat, binds to the GPR35 receptor to trigger inflammation and itching in psoriasis. Blocking this receptor in mouse models significantly reduced both inflammation and scratching behavior.

Oct 29, 2026·2 sources
00
Oct 28, 2026

Mayo Clinic study finds deep brain stimulation produces measurable brain changes within 18 minutes in epilepsy patients

Mayo Clinic researchers detected measurable brain changes within 18 minutes of deep brain stimulation in patients with drug-resistant epilepsy, a finding that could help clinicians personalize treatment settings without waiting months to assess effectiveness.

Oct 28, 2026·2 sources
00
Oct 22, 2026

McGill study links multiple schizophrenia symptoms to single brain signal

A new imaging study published in Science Advances has identified a single brain signal that may explain several distinct symptoms of schizophrenia, including altered perception, behavior, and speech patterns. The research suggests these seemingly separate problems may share a common neurological basis.

Oct 22, 2026·2 sources
00
Oct 21, 2026

OpenAI and Peter Thiel's Founders Fund invest in Coherence Neuro's cancer-detecting brain implant

Coherence Neuro has raised $45 million in funding from OpenAI's venture capital arm and Founders Fund to develop a brain implant designed to detect and treat cancer. The coin-sized device monitors tumor activity through neural signals.

Oct 21, 2026·2 sources
00
Oct 20, 2026

Rapport Therapeutics' RAP-219 meets primary endpoint in phase 2 bipolar mania trial

Rapport Therapeutics announced positive phase 2 results for RAP-219, an oral AMPA receptor modulator licensed from Johnson & Johnson, showing improvement in bipolar mania symptoms. This marks the company's second phase 2 success for the asset in 14 months.

Oct 20, 2026·3 sources
00
Oct 9, 2026

Outro raises $7 million to expand safe deprescribing platform for psychiatric medications

Outro, a New York-based neuroscience platform that helps patients safely discontinue psychiatric medications, announced it raised $7 million in combined pre-seed and seed funding. The funding will support the company's mission to close America's deprescribing gap and advance research in partnership with academic institutions.

Oct 9, 2026·2 sources
00
Oct 5, 2026

Optogenetic therapy shows promise in restoring vision for retinitis pigmentosa patients

A clinical trial of optogenetic therapy, based on Nobel Prize-winning research, demonstrated safety and partial vision restoration in patients with advanced retinitis pigmentosa, with 7 of 10 patients showing improved light sensitivity. The treatment uses gene therapy to engineer retinal cells to respond to light.

Oct 5, 2026·8 sources
00
Sep 20, 2026

Stanford scientists discover human brain develops from two separate ancient cell systems

Stanford University researchers have found that the human brain develops from two distinct cellular systems that evolved independently before fusing together, challenging the traditional understanding of brain development as originating from a single source. The discovery suggests evolution combined two ancient nervous systems with different functions, and may explain why certain hindbrain neurons have been difficult to study in laboratories.

Sep 20, 2026·5 sources
00
Sep 17, 2026

Scientists advance autism research with human brain organoids in mice and gene convergence study

Researchers have made two breakthrough advances in autism research: identifying convergent patterns among 1,200+ autism-risk genes in brain activity, and successfully implanting human brain organoids into engineered mice to create living models for testing treatments for autism and epilepsy.

Sep 17, 2026·2 sources
00
Jul 28, 2026

University researchers develop new human tissue model to study glioblastoma infiltration

Scientists at the University have created a new human tissue model that tracks how glioblastoma, an aggressive brain tumor, infiltrates surrounding brain tissue. The research aims to address the challenge of tumor recurrence after surgery, when remaining cells cause the cancer to return.

Jul 28, 2026·1 source
00
Jun 29, 2026

Meta AI unveils Brain2Qwerty system that decodes typed text from brain activity without implants

Meta AI researchers have developed Brain2Qwerty, a deep learning model that non-invasively decodes typed sentences from brain activity using external sensors, achieving an 18% character error rate. The breakthrough, published in Nature Neuroscience, represents a significant advance toward non-invasive brain-computer interfaces for communication.

Jun 29, 2026·3 sources
00
Apr 23, 2026

Dopamine Loss Emerges as Key Driver of Memory Decline in Alzheimer’s

Study finds reduced dopamine signaling contributes to memory decline in Alzheimer’s, highlighting a previously underrecognized pathway and potential target for treatment.

Apr 23, 2026·3 sources
00
Apr 20, 2026

Brain Study Links Microplastics to Health Risks

Analysis of human brain tissue shows microplastics and nanoplastics are present in both tumor and healthy samples, confirming their ability to cross into the brain, though their concentrations, distribution, and direct health effects remain uncertain and require further study.

Apr 20, 2026·2 sources
00

Top claims

  • ▪Ten years ago, a study led by Kristina Kigerl at Ohio State University showed in mice that spinal cord injury disrupted the gut microbiome and that probiotic administration had a protective effect.
  • ▪Ohio State neuroscientists and microbiologists combined metagenomic sequencing with time-resolved machine learning and artificial intelligence analytics to map gut microbial cross-talk.
  • ▪Kristina Kigerl co-led the Ohio State microbiome study alongside microbiology research scientist Ahmed Zayed and biophysics graduate Mohamed Mohssen.

People involved

Peter Thiel

Subtopics

Biomedical research4Drug Approval and Clinical Trials4Drug Policy, Pricing & Approval4Medical research4Brain health3Clinical trials3Mental Health & Wellbeing3Alzheimer’s & dementia2Biomedical engineering2Brain health & dementia researchers2Brain-computer interfaces2Drug development2Immunology2Implantable devices2Inflammation reduction & immune effects2Mental health2Neurological disorders2Psychosis & schizophrenia spectrum2Age related cognitive decline1AI in healthcare1AI research & benchmarks1AI startups1Alzheimer's disease1Assistive technology.1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories